Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam continuous pump versus intravenous bolus during general anesthesia
ChiCTR2000033534Phase 4Recruiting
- Sponsor
- Lianyungang Second People's Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam (2 arms), sponsored by Lianyungang Second People's Hospital. Primary endpoints: Bispectral Index and Observer's Assessment of Alertness/Sedation Scale. Started Jun 2020; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000033534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033534.